Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Neuronetics, Inc.STIM · Entity 6248 | Director · President and CEO | March 04, 2020 | March 05, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Neuronetics, Inc.
Report date March 04, 2020 · Filed March 05, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 249,811 |
Reported balance
After 2020-03-04 transaction · row 1
1 source rowRow 1 · 2020-03-04 · Exercise / conversion · Acquired 20,000 · Balance 249,811 |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.87 · Expires 2025-02-18 | Direct | 108,920 |
Reported balance
After 2020-03-04 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2020-03-04 · Exercise / conversion · Disposed 20,000 · Balance 108,920 F1: All of the stock options are vested. |
Filing footnotes · ownership attribution and instrument terms
F1: All of the stock options are vested.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 04, 2020 Filed Mar 5, 2020 01:16 UTC | Neuronetics, Inc. STIM · Entity 6248 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $0.87 | $0.00 |
DisclosureSEC source: 0000899243-20-007077 · doc4.xml · derivative · entry 2 Thatcher Christopher · CIK 0001744956 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,920 Underlying: Common Stock · 20,000 shares Expires 2025-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: All of the stock options are vested. Read SEC document |
| March 04, 2020 Filed Mar 5, 2020 01:16 UTC | Neuronetics, Inc. STIM · Entity 6248 | Exercise / conversionCommon Stock | 20,000 | $0.87 | $17,400.00 |
DisclosureSEC source: 0000899243-20-007077 · doc4.xml · nonDerivative · entry 1 Thatcher Christopher · CIK 0001744956 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 249,811 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 15, 2020 Filed Jan 17, 2020 21:27 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 175,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-003996 · doc4.xml · nonDerivative · entry 1 Thatcher Christopher · CIK 0001744956 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229,811 F1 · shares: One-third (1/3rd) of the shares subject to the restricted stock unit ("RSU") grant shall vest on each of January 15, 2021, January 15, 2022 and January 15, 2023, subject to Reporting Person continuing to provide service through each such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| September 04, 2019 Filed Sep 6, 2019 20:49 UTC | Neuronetics, Inc. STIM · Entity 6248 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $0.87 | $0.00 |
DisclosureSEC source: 0001209191-19-048778 · doc4.xml · derivative · entry 3 Thatcher Christopher · CIK 0001744956 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 355,297 Underlying: Common Stock · 20,000 shares Expires 2025-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Ten percent (10%) of the shares subject to the option vested on February 19, 2015, Twenty-five percent (25%) of the shares subject to the option vested on November 1, 2015, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date. Read SEC document |
| September 04, 2019 Filed Sep 6, 2019 20:49 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 20,000 | $10.74 | $214,700.00 |
DisclosureSEC source: 0001209191-19-048778 · doc4.xml · nonDerivative · entry 2 Thatcher Christopher · CIK 0001744956 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,811 F1 · kind: These shares were sold in compliance with a trading plan adopted by the reporting person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Read SEC document |
| September 04, 2019 Filed Sep 6, 2019 20:49 UTC | Neuronetics, Inc. STIM · Entity 6248 | Exercise / conversionCommon Stock | 20,000 | $0.87 | $17,400.00 |
DisclosureSEC source: 0001209191-19-048778 · doc4.xml · nonDerivative · entry 1 Thatcher Christopher · CIK 0001744956 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,811 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 08, 2019 Filed Apr 8, 2019 22:26 UTC | Neuronetics, Inc. STIM · Entity 6248 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $0.87 | $0.00 |
DisclosureSEC source: 0001209191-19-024035 · doc4.xml · derivative · entry 3 Thatcher Christopher · CIK 0001744956 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375,297 Underlying: Common Stock · 15,000 shares Expires 2025-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Ten percent (10%) of the shares subject to the option vested on February 19, 2015, Twenty-five percent (25%) of the shares subject to the option vested on November 1, 2015, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date. Read SEC document |
| April 08, 2019 Filed Apr 8, 2019 22:26 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 15,000 | $16.82 | $252,300.00 |
DisclosureSEC source: 0001209191-19-024035 · doc4.xml · nonDerivative · entry 2 Thatcher Christopher · CIK 0001744956 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,811 F1 · kind: These shares were sold in compliance with a trading plan adopted by the reporting person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.545 to $16.955 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| April 08, 2019 Filed Apr 8, 2019 22:26 UTC | Neuronetics, Inc. STIM · Entity 6248 | Exercise / conversionCommon Stock | 15,000 | $0.87 | $13,050.00 |
DisclosureSEC source: 0001209191-19-024035 · doc4.xml · nonDerivative · entry 1 Thatcher Christopher · CIK 0001744956 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,811 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 23:14 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantEmployee Stock Option (right to buy) · Derivative | 96,463 | $0.00 Strike: $16.42 | $0.00 |
DisclosureSEC source: 0001209191-19-018613 · doc4.xml · derivative · entry 2 Thatcher Christopher · CIK 0001744956 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,463 Underlying: Common Stock · 96,463 shares Expires 2029-03-08 F3 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option shall vest on March 8, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 23:14 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 54,811 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-018613 · doc4.xml · nonDerivative · entry 1 Thatcher Christopher · CIK 0001744956 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,811 F1 · shares: Twenty-five percent (25%) of the shares subject to the restricted stock unit ("RSU") grant shall vest on each of March 8, 2020 and March 8, 2021, and fifty percent (50%) of the shares subject to the RSU grant shall vest on March 8, 2022, subject to Reporting Person continuing to provide service through each such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.